SCHEMBL5215156

SCHEMBL5215156

Cc1ccc(COc2ccc(C=O)cc2OCc2ccccc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR2 P21452 1/20 0.61
MAOA P21397 2/20 0.59
MAOB P27338 2/20 0.59
AKR1C3 P42330 1/20 0.56
ALDH1A1 P00352 7/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
GAA P10253 2/20 0.55
KDM4E B2RXH2 2/20 0.54
LMNA P02545 2/20 0.54
PDCD1 Q15116 1/20 0.52
CD274 Q9NZQ7 1/20 0.52
MAPT P10636 5/20 0.51
HPGD P15428 3/20 0.51
L3MBTL1 Q9Y468 3/20 0.51
KMT2A Q03164 2/20 0.51
NPSR1 Q6W5P4 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
GSK3B P49841 1/20 0.51
MEN1 O00255 1/20 0.51
HTT P42858 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL584489 0.91 TACR2 (0.62) TACR2MAOAMAOBALDH1A1SMN1; SMN2
SCHEMBL29446267 0.91 TACR2 (0.62) TACR2MAOAMAOBALDH1A1SMN1; SMN2
SCHEMBL14682675 0.87 TACR2 (0.80) TACR2MAOAMAOBALDH1A1SMN1; SMN2
SCHEMBL12517074 0.87 ALDH1A1 (0.66) TACR2MAOAMAOBALDH1A1SMN1; SMN2
SCHEMBL1609108 0.87 TACR2 (0.75) TACR2MAOAMAOBALDH1A1SMN1; SMN2
SCHEMBL662145 0.87 TACR2 (0.75) TACR2MAOAMAOBALDH1A1SMN1; SMN2
SCHEMBL2463491 0.86 NPC1 (0.63) TACR2MAOAMAOBALDH1A1SMN1; SMN2
SCHEMBL5216320 0.86 TACR2 (0.78) TACR2MAOAMAOBAKR1C3ALDH1A1
SCHEMBL752160 0.85 ALDH1A1 (0.65) TACR2MAOAMAOBALDH1A1SMN1; SMN2
SCHEMBL29377794 0.85 ALDH1A1 (0.65) TACR2MAOAMAOBALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313471-B1 BENZYLIDENE THIAZOLIDINEDIONES AND THEIR USE AS ANTIMYCOTIC AGENTS UCB SA (BE) 2007-04-11 EP disclosed
US-7105554-B2 Benzylidene thiazolidinediones and their use as antimycotic agents OXFORD GLYCOSCIENCES (UK) LTD. (GB) 2006-09-12 US disclosed
US-20040006112-A1 Benzylidene thiazolidinediones and their use as antimycotic agents OXFORD GLYCOSCIENCES (UK) LTD (GB) 2004-01-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006112-A1 Benzylidene thiazolidinediones and their use as antimycotic agents SLC5A2, OXSR1, SLC5A1 TACR2 960/4885MAOA 3863/4885MAOB 3132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.